chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Feeling abnormal, Nausea, Pyrexia, Vomiting
Clinical narrative: fever of 101°F-103°F; not been able to keep anything beside clear liquids down. She cannot eat; did not feel good; not been able to keep anything beside clear liquids down. She cannot eat; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (did not feel good), DECREASED APPETITE (not been able to keep anything beside clear liquids down. She cannot eat), VOMITING (vomiting), PYREXIA (fever of 101°F-103°F) and NAUSEA (not been able to keep anything beside clear liquids down. She cannot eat) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 048B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced FEELING ABNORMAL (did not feel good), DECREASED APPETITE (not been able to keep anything beside clear liquids down. She cannot eat), VOMITING (vomiting) and NAUSEA (not been able to keep anything beside clear liquids down. She cannot eat). On 23-Apr-2021, the patient experienced PYREXIA (fever of 101°F-103°F). At the time of the report, FEELING ABNORMAL (did not feel good), DECREASED APPETITE (not been able to keep anything beside clear liquids down. She cannot eat), VOMITING (vomiting), PYREXIA (fever of 101°F-103°F) and NAUSEA (not been able to keep anything beside clear liquids down. She cannot eat) outcome was unknown.            Treatment was reported as Tylenol. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was Not applicable. No treatment medication provided by the reporter.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Treatment noncompliance, Vaccination site discomfort
Clinical narrative: she said she is going to have the residency vaccines that are required and maybe won´t get the 2nd dose of the Moderna vaccine; Right shoulder red; Some minor discomfort at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Right shoulder red), VACCINATION SITE DISCOMFORT (Some minor discomfort at the injection site) and TREATMENT NONCOMPLIANCE (she said she is going to have the residency vaccines that are required and maybe won´t get the 2nd dose of the Moderna vaccine) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced ERYTHEMA (Right shoulder red) and VACCINATION SITE DISCOMFORT (Some minor discomfort at the injection site). On an unknown date, the patient experienced TREATMENT NONCOMPLIANCE (she said she is going to have the residency vaccines that are required and maybe won´t get the 2nd dose of the Moderna vaccine). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Right shoulder red), VACCINATION SITE DISCOMFORT (Some minor discomfort at the injection site) and TREATMENT NONCOMPLIANCE (she said she is going to have the residency vaccines that are required and maybe won´t get the 2nd dose of the Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy spells when patient gets out of bed or when he sits or stands from sitting position; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy spells when patient gets out of bed or when he sits or stands from sitting position) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and LOT040B21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, HYDROCHLOROTHIAZIDE and SIMVASTATIN for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced DIZZINESS (Dizzy spells when patient gets out of bed or when he sits or stands from sitting position). At the time of the report, DIZZINESS (Dizzy spells when patient gets out of bed or when he sits or stands from sitting position) outcome was unknown.            Concomitant products included lisinopril, hydrochlorothiazide and simvastatin for unknown indication   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up received on 27-5-21 via TCR.Denied further follow up
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Diarrhoea, Eye pain, Headache
Clinical narrative: pain in his eye; diarrhea; really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (pain in his eye), DIARRHOEA (diarrhea) and HEADACHE (really bad headache) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes (Diabetes), Hypertension, Blindness, Hearing loss and Eye abnormality (Ischemic neuropathy of bilateral eyes). Concomitant products included CLONIDINE, LISINOPRIL, AMLODIPINE BESILATE (NORVASC) and CARVEDILOL (COREG) for an unknown indication.   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced EYE PAIN (pain in his eye), DIARRHOEA (diarrhea) and HEADACHE (really bad headache). On 22-Apr-2021, EYE PAIN (pain in his eye) and DIARRHOEA (diarrhea) had resolved. At the time of the report, HEADACHE (really bad headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, Blood pressure measurement: 225/92 (High) 225/92 Blood pressure increased.         Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Non-Significant Follow Up received contains NNI.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Crying, Depression
Clinical narrative: depression is worse since getting the second dose; feeling really blah and on the weepy side; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSION (depression is worse since getting the second dose) and CRYING (feeling really blah and on the weepy side) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 019B21a) for COVID-19 vaccination.     Previously administered products included for an unreported indication: . Concurrent medical conditions included Clinical depression. Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) and METFORMIN for an unknown indication.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DEPRESSION (depression is worse since getting the second dose) and CRYING (feeling really blah and on the weepy side). At the time of the report, DEPRESSION (depression is worse since getting the second dose) and CRYING (feeling really blah and on the weepy side) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: passed the recommended time frame for second dose; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (passed the recommended time frame for second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) unknown route, Unknown dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (passed the recommended time frame for second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (passed the recommended time frame for second dose) had resolved. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Swelling
Clinical narrative: his armpit swelled on his left arm; fever; body aches; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (his armpit swelled on his left arm), PYREXIA (fever) and MYALGIA (body aches) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced SWELLING (his armpit swelled on his left arm), PYREXIA (fever) and MYALGIA (body aches). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 26-Apr-2021, PYREXIA (fever) and MYALGIA (body aches) had resolved. At the time of the report, SWELLING (his armpit swelled on his left arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: soreness in her arm; little fever.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness in her arm) and PYREXIA (little fever.) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No relevant medical history provided.  Concomitant products included DULOXETINE for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PAIN (soreness in her arm) and PYREXIA (little fever.). At the time of the report, VACCINATION SITE PAIN (soreness in her arm) and PYREXIA (little fever.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product also included birth control medication.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-090321 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090321:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest discomfort, Chills, Dyspnoea, Ear pain
Clinical narrative: Shortness of breath; Middle of back and buttocks are still sore; Piercing ear pain; Cramps; Sweating profusely; Couldn't get out of bed; Tightness in the chest; Similar feeling to lingering symptoms after the flu; Body ache; A little tired; Headache; Chills; Major fever; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps) and HYPERHIDROSIS (Sweating profusely) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Apr-2021, the patient experienced DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps), HYPERHIDROSIS (Sweating profusely), ASTHENIA (Couldn't get out of bed), CHEST DISCOMFORT (Tightness in the chest), INFLUENZA LIKE ILLNESS (Similar feeling to lingering symptoms after the flu), MYALGIA (Body ache), FATIGUE (A little tired), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Major fever). On 26-Apr-2021, CHILLS (Chills) and PYREXIA (Major fever) had resolved. At the time of the report, DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps), HYPERHIDROSIS (Sweating profusely), ASTHENIA (Couldn't get out of bed), CHEST DISCOMFORT (Tightness in the chest), INFLUENZA LIKE ILLNESS (Similar feeling to lingering symptoms after the flu), MYALGIA (Body ache), FATIGUE (A little tired) and HEADACHE (Headache) outcome was unknown.            Treatment include Tylenol.  Concomitant medication was not reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hyperhidrosis, Influenza like illness, Muscle spasms
Clinical narrative: Shortness of breath; Middle of back and buttocks are still sore; Piercing ear pain; Cramps; Sweating profusely; Couldn't get out of bed; Tightness in the chest; Similar feeling to lingering symptoms after the flu; Body ache; A little tired; Headache; Chills; Major fever; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps) and HYPERHIDROSIS (Sweating profusely) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Apr-2021, the patient experienced DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps), HYPERHIDROSIS (Sweating profusely), ASTHENIA (Couldn't get out of bed), CHEST DISCOMFORT (Tightness in the chest), INFLUENZA LIKE ILLNESS (Similar feeling to lingering symptoms after the flu), MYALGIA (Body ache), FATIGUE (A little tired), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Major fever). On 26-Apr-2021, CHILLS (Chills) and PYREXIA (Major fever) had resolved. At the time of the report, DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps), HYPERHIDROSIS (Sweating profusely), ASTHENIA (Couldn't get out of bed), CHEST DISCOMFORT (Tightness in the chest), INFLUENZA LIKE ILLNESS (Similar feeling to lingering symptoms after the flu), MYALGIA (Body ache), FATIGUE (A little tired) and HEADACHE (Headache) outcome was unknown.            Treatment include Tylenol.  Concomitant medication was not reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pyrexia
Clinical narrative: Shortness of breath; Middle of back and buttocks are still sore; Piercing ear pain; Cramps; Sweating profusely; Couldn't get out of bed; Tightness in the chest; Similar feeling to lingering symptoms after the flu; Body ache; A little tired; Headache; Chills; Major fever; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps) and HYPERHIDROSIS (Sweating profusely) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Apr-2021, the patient experienced DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps), HYPERHIDROSIS (Sweating profusely), ASTHENIA (Couldn't get out of bed), CHEST DISCOMFORT (Tightness in the chest), INFLUENZA LIKE ILLNESS (Similar feeling to lingering symptoms after the flu), MYALGIA (Body ache), FATIGUE (A little tired), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Major fever). On 26-Apr-2021, CHILLS (Chills) and PYREXIA (Major fever) had resolved. At the time of the report, DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps), HYPERHIDROSIS (Sweating profusely), ASTHENIA (Couldn't get out of bed), CHEST DISCOMFORT (Tightness in the chest), INFLUENZA LIKE ILLNESS (Similar feeling to lingering symptoms after the flu), MYALGIA (Body ache), FATIGUE (A little tired) and HEADACHE (Headache) outcome was unknown.            Treatment include Tylenol.  Concomitant medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: broke out; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (broke out) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (broke out). At the time of the report, ADVERSE EVENT (broke out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported treatment medications were reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Little soreness in arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Little soreness in arm at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE PAIN (Little soreness in arm at injection site). On 17-Mar-2021, VACCINATION SITE PAIN (Little soreness in arm at injection site) had resolved. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable. Concomitant medication was not reported.  No treatment information was reported.   This case was linked to MOD-2021-018613 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Limb discomfort, Musculoskeletal discomfort, Pain in extremity
Clinical narrative: pain in arm; locked shoulder;This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), MUSCULOSKELETAL DISCOMFORT (locked shoulder), PERIPHERAL SWELLING (swollen hand), LIMB DISCOMFORT (can not use left arm) and ARTHRALGIA (joint pain, shoulder pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced ARTHRALGIA (joint pain, shoulder pain) and CHILLS (chills). On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), MUSCULOSKELETAL DISCOMFORT (locked shoulder), PERIPHERAL SWELLING (swollen hand) and LIMB DISCOMFORT (can not use left arm). On 04-Mar-2021, ARTHRALGIA (joint pain, shoulder pain) and CHILLS (chills) had resolved. At the time of the report, PAIN IN EXTREMITY (pain in arm), MUSCULOSKELETAL DISCOMFORT (locked shoulder), PERIPHERAL SWELLING (swollen hand) and LIMB DISCOMFORT (can not use left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient ended up at emergency room for shoulder lock  Concomitant medication was not reported. Treatment information was not provided by the reporter.   This case was linked to MOD-2021-090326 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: pain in arm; locked shoulder;This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), MUSCULOSKELETAL DISCOMFORT (locked shoulder), PERIPHERAL SWELLING (swollen hand), LIMB DISCOMFORT (can not use left arm) and ARTHRALGIA (joint pain, shoulder pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced ARTHRALGIA (joint pain, shoulder pain) and CHILLS (chills). On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), MUSCULOSKELETAL DISCOMFORT (locked shoulder), PERIPHERAL SWELLING (swollen hand) and LIMB DISCOMFORT (can not use left arm). On 04-Mar-2021, ARTHRALGIA (joint pain, shoulder pain) and CHILLS (chills) had resolved. At the time of the report, PAIN IN EXTREMITY (pain in arm), MUSCULOSKELETAL DISCOMFORT (locked shoulder), PERIPHERAL SWELLING (swollen hand) and LIMB DISCOMFORT (can not use left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient ended up at emergency room for shoulder lock  Concomitant medication was not reported. Treatment information was not provided by the reporter.   This case was linked to MOD-2021-090326 (Patient Link).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: She just had a rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (She just had a rash) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE RASH (She just had a rash). At the time of the report, VACCINATION SITE RASH (She just had a rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She did share that over a month before her 1st injection she had Juvederm and botox No concomitant medication was reported . No treatment medication was reported .   This case was linked to MOD-2021-090333 (Patient Link).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Regular fever; Regular chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Regular fever) and CHILLS (Regular chills) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS, PARACETAMOL (TYLENOL) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PYREXIA (Regular fever) and CHILLS (Regular chills). On 27-Mar-2021, PYREXIA (Regular fever) and CHILLS (Regular chills) had resolved.            This case was linked to MOD-2021-090389 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Injection site erythema, Injection site mass, Injection site pruritus
Clinical narrative: lump the size of a silver dollar at injection site; dizzy; No energy; itchiness at injection site; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (lump the size of a silver dollar at injection site), DIZZINESS (dizzy), ASTHENIA (No energy), INJECTION SITE PRURITUS (itchiness at injection site) and INJECTION SITE ERYTHEMA (redness at injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE MASS (lump the size of a silver dollar at injection site), DIZZINESS (dizzy), ASTHENIA (No energy), INJECTION SITE PRURITUS (itchiness at injection site) and INJECTION SITE ERYTHEMA (redness at injection site). The patient was treated with MAGNESIUM SULFATE (EPSOM SALT) for Injection site pruritus, at an unspecified dose and frequency. At the time of the report, INJECTION SITE MASS (lump the size of a silver dollar at injection site), DIZZINESS (dizzy), ASTHENIA (No energy), INJECTION SITE PRURITUS (itchiness at injection site) and INJECTION SITE ERYTHEMA (redness at injection site) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No relevant concomitant medications were reported.   This case was linked to MOD-2021-179851 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up information received on 27-MAY 2021 contains event outcome details updated to recovered from unknown. Treatment information was updated.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Ear pain, Hypoaesthesia, Neck pain, Sinusitis
Clinical narrative: Sinus infection; Dizziness; Neck pain; Ear pain in left side; Arm numbness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SINUSITIS (Sinus infection), DIZZINESS (Dizziness), NECK PAIN (Neck pain), EAR PAIN (Ear pain in left side) and HYPOAESTHESIA (Arm numbness) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (Sinus infection), DIZZINESS (Dizziness), NECK PAIN (Neck pain), EAR PAIN (Ear pain in left side) and HYPOAESTHESIA (Arm numbness). The patient was treated with IBUPROFEN (ADVIL ULTRA [IBUPROFEN]) at an unspecified dose and frequency; DIMENHYDRINATE (DRAMAMINE) at an unspecified dose and frequency and XYLOMETAZOLINE HYDROCHLORIDE (SUDAFED [XYLOMETAZOLINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SINUSITIS (Sinus infection), DIZZINESS (Dizziness), NECK PAIN (Neck pain), EAR PAIN (Ear pain in left side) and HYPOAESTHESIA (Arm numbness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concurrent medication was reported by patient.   This case was linked to MOD-2021-090350 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow up received on 27-5-2021 contains no new information.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Ocular hyperaemia, Vision blurred, Visual field defect, Visual impairment
Clinical narrative: vision problems in the right eye; her right eye is really swollen; red eye; hard to see; peripheral vision is obstructed; blotches in eye; This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (vision problems in the right eye), EYE SWELLING (her right eye is really swollen), OCULAR HYPERAEMIA (red eye), VISION BLURRED (hard to see) and VISUAL FIELD DEFECT (peripheral vision is obstructed) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DULOXETINE for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced VISUAL IMPAIRMENT (vision problems in the right eye), EYE SWELLING (her right eye is really swollen), OCULAR HYPERAEMIA (red eye), VISION BLURRED (hard to see), VISUAL FIELD DEFECT (peripheral vision is obstructed) and VITREOUS FLOATERS (blotches in eye). At the time of the report, VISUAL IMPAIRMENT (vision problems in the right eye), EYE SWELLING (her right eye is really swollen), OCULAR HYPERAEMIA (red eye), VISION BLURRED (hard to see), VISUAL FIELD DEFECT (peripheral vision is obstructed) and VITREOUS FLOATERS (blotches in eye) outcome was unknown.            Concomitant product also includes Birth control medication.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-090307 (E2B Linked Report); Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090307:1st dose
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vitreous floaters
Clinical narrative: vision problems in the right eye; her right eye is really swollen; red eye; hard to see; peripheral vision is obstructed; blotches in eye; This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (vision problems in the right eye), EYE SWELLING (her right eye is really swollen), OCULAR HYPERAEMIA (red eye), VISION BLURRED (hard to see) and VISUAL FIELD DEFECT (peripheral vision is obstructed) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DULOXETINE for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced VISUAL IMPAIRMENT (vision problems in the right eye), EYE SWELLING (her right eye is really swollen), OCULAR HYPERAEMIA (red eye), VISION BLURRED (hard to see), VISUAL FIELD DEFECT (peripheral vision is obstructed) and VITREOUS FLOATERS (blotches in eye). At the time of the report, VISUAL IMPAIRMENT (vision problems in the right eye), EYE SWELLING (her right eye is really swollen), OCULAR HYPERAEMIA (red eye), VISION BLURRED (hard to see), VISUAL FIELD DEFECT (peripheral vision is obstructed) and VITREOUS FLOATERS (blotches in eye) outcome was unknown.            Concomitant product also includes Birth control medication.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-090307 (E2B Linked Report); Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090307:1st dose
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Influenza like illness, Pyrexia
Clinical narrative: flu symptoms; felt pretty miserable/ miserable all day; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu symptoms), FEELING ABNORMAL (felt pretty miserable/ miserable all day) and PYREXIA (low grade fever) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 01SM20) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu symptoms), FEELING ABNORMAL (felt pretty miserable/ miserable all day) and PYREXIA (low grade fever). On 10-Mar-2021, INFLUENZA LIKE ILLNESS (flu symptoms), FEELING ABNORMAL (felt pretty miserable/ miserable all day) and PYREXIA (low grade fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 100 (High) 100 degrees Fahrenheit.         No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-033598 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Vaccination site pain, Vaccination site warmth
Clinical narrative: Heat generation; Red rash "down her injection arm" (Left); Tenderness at the injection site; Right arm  now has a similar rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Heat generation), RASH ERYTHEMATOUS (Red rash "down her injection arm" (Left)), RASH (Right arm  now has a similar rash) and VACCINATION SITE PAIN (Tenderness at the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced RASH (Right arm  now has a similar rash). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Heat generation), RASH ERYTHEMATOUS (Red rash "down her injection arm" (Left)) and VACCINATION SITE PAIN (Tenderness at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Heat generation), RASH ERYTHEMATOUS (Red rash "down her injection arm" (Left)), RASH (Right arm  now has a similar rash) and VACCINATION SITE PAIN (Tenderness at the injection site) had not resolved.            No concomitant medications were provided. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: 1st dose leaked on patients arm after administering; This spontaneous case was reported by a physician and describes the occurrence of INCORRECT DOSE ADMINISTERED (1st dose leaked on patients arm after administering) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (1st dose leaked on patients arm after administering). At the time of the report, INCORRECT DOSE ADMINISTERED (1st dose leaked on patients arm after administering) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Limb discomfort, Pain in extremity, Peripheral swelling
Clinical narrative: pain in arm; swollen hand; locked shoulder; can not use left arm; joint pain; chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Apr-2021 and was forwarded to Moderna on 26-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), PERIPHERAL SWELLING (swollen hand), SHOULDER DEFORMITY (locked shoulder), LIMB DISCOMFORT (can not use left arm) and ARTHRALGIA (joint pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced ARTHRALGIA (joint pain) and CHILLS (chills). On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), PERIPHERAL SWELLING (swollen hand), SHOULDER DEFORMITY (locked shoulder) and LIMB DISCOMFORT (can not use left arm). On 04-Mar-2021, ARTHRALGIA (joint pain) and CHILLS (chills) had resolved. At the time of the report, PAIN IN EXTREMITY (pain in arm), PERIPHERAL SWELLING (swollen hand), SHOULDER DEFORMITY (locked shoulder) and LIMB DISCOMFORT (can not use left arm) outcome was unknown. Not Provided          This case was linked to MOD-2021-090311 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Shoulder deformity
Clinical narrative: pain in arm; swollen hand; locked shoulder; can not use left arm; joint pain; chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Apr-2021 and was forwarded to Moderna on 26-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), PERIPHERAL SWELLING (swollen hand), SHOULDER DEFORMITY (locked shoulder), LIMB DISCOMFORT (can not use left arm) and ARTHRALGIA (joint pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced ARTHRALGIA (joint pain) and CHILLS (chills). On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), PERIPHERAL SWELLING (swollen hand), SHOULDER DEFORMITY (locked shoulder) and LIMB DISCOMFORT (can not use left arm). On 04-Mar-2021, ARTHRALGIA (joint pain) and CHILLS (chills) had resolved. At the time of the report, PAIN IN EXTREMITY (pain in arm), PERIPHERAL SWELLING (swollen hand), SHOULDER DEFORMITY (locked shoulder) and LIMB DISCOMFORT (can not use left arm) outcome was unknown. Not Provided          This case was linked to MOD-2021-090311 (Patient Link).
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Thrombophlebitis superficial
Clinical narrative: Blood clot in right calf; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THROMBOPHLEBITIS SUPERFICIAL (Blood clot in right calf) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced THROMBOPHLEBITIS SUPERFICIAL (Blood clot in right calf). At the time of the report, THROMBOPHLEBITIS SUPERFICIAL (Blood clot in right calf) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory investigations were provided. The Treatment information included rivaroxaban (Xarelto).  Based on current available information and the temporal association between product use and the start date of the event a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Updated Vaccine information and added batch/Lot number, expiry date. Updated  event to blood clot in right calf. Added treatment medication.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the event a causal relationship cannot be excluded.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Puffiness of the face on the left side for her son; This spontaneous case was reported by an other health care professional and describes the occurrence of SWELLING FACE (Puffiness of the face on the left side) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     Concurrent medical conditions included Autism.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced SWELLING FACE (Puffiness of the face on the left side). The patient was treated with BENADRYL for Adverse event, at an unspecified dose and frequency and TYLENOL for Adverse event, at an unspecified dose and frequency. At the time of the report, SWELLING FACE (Puffiness of the face on the left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Itches every now and then; Red ring at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itches every now and then) and VACCINATION SITE ERYTHEMA (Red ring at injection site) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itches every now and then) and VACCINATION SITE ERYTHEMA (Red ring at injection site). At the time of the report, VACCINATION SITE PRURITUS (Itches every now and then) and VACCINATION SITE ERYTHEMA (Red ring at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up received on 03 Jun 2021 contains non-significant information: Updated reporter information.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye swelling, Fatigue, Headache, Limb discomfort
Clinical narrative: rash; congestion; nausea; Chills; Headache; Face swollen from cheeks up; Eyes swollen; Hard time lifting arm; Chills; severe headache; Fatigue; Injection site achiness; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (congestion), EYE SWELLING (Eyes swollen), LIMB DISCOMFORT (Hard time lifting arm), SWELLING FACE (Face swollen from cheeks up) and RASH (rash) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced LIMB DISCOMFORT (Hard time lifting arm), the first episode of CHILLS (Chills), HEADACHE (severe headache), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Injection site achiness). On 25-Apr-2021, the patient experienced EYE SWELLING (Eyes swollen). On 26-Apr-2021, the patient experienced SWELLING FACE (Face swollen from cheeks up). On 28-Apr-2021, the patient experienced NASAL CONGESTION (congestion), NAUSEA (nausea), the second episode of CHILLS (Chills) and HEADACHE (Headache). On an unknown date, the patient experienced RASH (rash). At the time of the report, NASAL CONGESTION (congestion), EYE SWELLING (Eyes swollen), LIMB DISCOMFORT (Hard time lifting arm), SWELLING FACE (Face swollen from cheeks up), RASH (rash), HEADACHE (severe headache), FATIGUE (Fatigue), VACCINATION SITE PAIN (Injection site achiness), NAUSEA (nausea), the last episode of CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.            This case was linked to MOD-2021-090312 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: No specific follow-up information recorded.